[{"Assets_0_Q2_USD":140527000.0,"CommonStockSharesOutstanding_0_Q2_shares":48574985.0,"NetIncomeLoss_2_Q2_USD":-15236000.0,"NetIncomeLoss_1_Q2_USD":-9240000.0,"StockholdersEquity_0_Q2_USD":40915000.0,"Ticker":"CCXI","CIK":"1340652","name":"CHEMOCENTRYX, INC.","OfficialName":"ChemoCentryx Inc. Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1508212562.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170808"}]